NCT06412952View on ClinicalTrials.gov

68Ga-NOTA-RM26 PET/CT in Glioma Patients

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Glioma
Interventions
DRUG

68Ga-RM26

Intravenous injection of one dosage of 74-185 MBq(2-5 mCi) 68Ga-RM26. Tracer doses of 68Ga- RM26 will be used to image lesions of glioma by PET/CT.

Trial Locations (1)

100730

RECRUITING

Chinese Academy of Medical Science & Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER